Status:
UNKNOWN
Does the Use of Fiasp vs. Asp Lead to the Prolonged TIR in Children With Type 1 Diabetes?
Lead Sponsor:
Medical University of Warsaw
Conditions:
Diabetes type1
Diabetes Mellitus, Type 1
Eligibility:
All Genders
6-17 years
Phase:
PHASE4
Brief Summary
The aim of the study is to assess whether the implementation of faster insulin aspart in children with Type 1 diabetes treated with intensive insulin therapy with the use of an insulin pump and using ...
Eligibility Criteria
Inclusion
- ≥1 year of a history of type 1 diabetes;
- treatment with intensive insulin therapy with the use of an insulin pump (continuous subcutaneous insulin infusion, CSII) ≥3 months;
- using continuous glucose monitoring system for at least 1 month;
- HbA1c\<8%;
- consent to participate in the study obtained from the parent and the patient (\>16 years of age).
Exclusion
- diabetes treated with multiple insulin injections with insulin pens (Multiple Daily Injections, MDI);
- concomitant medical problems which might significantly affect glucose levels;
- the withdrawal of the consent to participate in the study.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT04772729
Start Date
March 1 2021
End Date
March 1 2024
Last Update
February 26 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.